Bruce L. A. Carter, Director at Regulus Therapeutics Inc. (RGLS), sold 20,000 shares at $17.66 ($353K) on 2015-04-13, disclosed to the SEC on 2015-04-14.
Open-market sale of $353k RGLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |